CALC
Kenneth A. Stauderman, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kenneth A. Stauderman, Ph.D.
CalciMedica, Inc. reported in an 8-K filed March 22, 2023 that Kenneth A. Stauderman, Ph.D. was appointed Chief Scientific Officer.
“At the effective time of the Merger, the Company's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
CalciMedica, Inc. (CALC)
SEC 8-K
Current2023-03-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at CalciMedica, Inc.
Other people whose current roles at this company are on record from its filings.
- A. Rachel Leheny CEO, Board Member
- A. Rachel Leheny, Ph.D. CEO, Board Member
- Ann Rachel Leheny CEO
- Ann Rachel Leheny, Ph.D. CEO
- Eric W. Roberts Chairman
- Robert N. Wilson Chairman, Board Member
- Daniel Geffken, MBA CFO, Chief Accounting Officer
- Stephen Bardin CFO, Chief Accounting Officer
- Michael J. Dunn COO
- Michael J. Dunn, MBA COO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.